Nuveen’s Rubius Therapeutics RUBY Stock Holding History
Bought
Maintained
Sold
Other funds holding RUBY
AG
Nuveen's RUBY Position: Q2 2022 in Review
Nuveen sold out of Rubius Therapeutics (RUBY) in Q2 2022, closing a stake of 184,772 shares — an estimated $1.02M sold.
Nuveen first reported a position in RUBY in Q2 2019 and held it in 12 quarters. The position peaked at $4.23M in Q1 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.
- Nuveen reported no remaining Rubius Therapeutics position as of Q2 2022 after selling out during the quarter.
- Nuveen sold 184,772 Rubius Therapeutics shares in Q2 2022, an estimated $1.02M.
- Nuveen first reported a position in Rubius Therapeutics in Q2 2019 and held it in 12 quarters.
- Nuveen's Rubius Therapeutics position peaked at $4.23M in Q1 2021.
- 72 funds tracked by Wall St. Rank held Rubius Therapeutics as of Q2 2022.
Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.